RecruitingNot applicableNCT07316504
Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions
Studying Orofaciodigital syndrome type 1
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Clermont-Ferrand
- Principal Investigator
- Géraud Souteyrand, MD, PhDCHU de Clermont-Ferrand
- Intervention
- Intravascular lithotripsy(procedure)
- Enrollment
- 80 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2031
Study locations (2)
- Clermont Ferrand Hospital, Clermont-Ferrand, Auvergne, France
- CHU de Clermont-Ferrand, Clermont-Ferrand, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07316504 on ClinicalTrials.govOther trials for Orofaciodigital syndrome type 1
Additional recruiting or active studies for the same condition.